Quick Takeaways
- MILLENNIUM MANAGEMENT LLC filed SCHEDULE 13G for Verve Therapeutics, Inc. Common Stock, par value $0.001 per share (VERV).
- Disclosed ownership: 4.9%.
- Date of event: 22 Apr 2025.
MILLENNIUM MANAGEMENT LLC - 22 Apr 2025 SCHEDULE 13G Report for Verve Therapeutics, Inc. Common Stock, par value $0.001 per share (VERV)
- Filing Manager
- MILLENNIUM MANAGEMENT LLC
- Reporting Manager
- Millennium Management LLC
- Symbol
- VERV
- Shares outstanding
- 88,310,755 shares
- Disclosed Ownership
- 4,327,227 shares
- Ownership
- 4.9%
- Form type
- SCHEDULE 13G
- Filing time
- 29 Apr 2025, 16:01:45 UTC
- Date of event
- 22 Apr 2025
- Previous filing
- 31 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MILLENNIUM MANAGEMENT LLC disclosed 4.9% ownership in Verve Therapeutics, Inc. Common Stock, par value $0.001 per share (VERV) on 22 Apr 2025."
What Changed
- Previous schedule filing date: 31 Jan 2025.
- Current filing was accepted on 29 Apr 2025, 16:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Millennium Management LLC | 4.9% | 4,327,227 | 0 | 4,327,227 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 4.9% | 4,327,227 | 0 | 4,327,227 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 4.9% | 4,327,227 | 0 | 4,327,227 | /s/ Israel A. Englander | Israel A. Englander |